[ACRS] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
06-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 1.04%
YoY- -37.83%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 2,766 2,398 17,570 9,282 1,869 2,528 7,753 -49.72%
PBT -10,986 -16,941 -1,858 -29,261 -29,569 -28,160 -27,635 -45.96%
Tax 0 200 -367 -219 -1,500 -1,758 5,656 -
NP -10,986 -16,941 -1,491 -29,261 -29,569 -26,402 -33,291 -52.27%
Tax Rate - - - - - - - -
Total Cost 13,752 19,339 19,061 38,543 31,438 28,930 41,044 -51.79%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -397.18 -706.46 -8.49 -315.24 -1,582.08 -1,044.38 -429.40 -5.07%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.15 -0.24 -0.02 -0.41 -0.42 -0.39 -0.50 -55.21%
EPS Diluted -0.15 -0.24 -0.02 -0.41 -0.42 -0.39 -0.50 -55.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.